SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-21-005701
Filing Date
2021-05-14
Accepted
2021-05-14 16:09:26
Documents
3
Period of Report
2021-05-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT vtgn8k_may2021.htm 8-K 33376
2 UNDERWRITING AGREEMENT ex1-1.htm EX-1.1 275394
3 OPINION OF WOODBURN AND WEDGE ex5-1.htm EX-5 33786
  Complete submission text file 0001654954-21-005701.txt   343771
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
VistaGen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-37761 | Film No.: 21924633
SIC: 2834 Pharmaceutical Preparations